PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
128 hedge funds and large institutions have $265M invested in Aratana Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
28% more funds holding
Funds holding: 100 → 128 (+28)
18% less call options, than puts
Call options by funds: $178K | Put options by funds: $218K
Holders
128
Holding in Top 10
3
Calls
$178K
Puts
$218K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$5.53M | |
| 3 | +$2.68M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.57M |
| 5 |
Millennium Management
New York
|
+$2.52M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$9.53M | |
| 3 | -$8.12M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.9M |
| 5 |
BC
Broadfin Capital
New York
|
-$3.21M |